1. Home
  2. BNTC vs CGC Comparison

BNTC vs CGC Comparison

Compare BNTC & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

N/A

Current Price

$9.20

Market Cap

344.4M

Sector

Health Care

ML Signal

N/A

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

N/A

Current Price

$0.57

Market Cap

299.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNTC
CGC
Founded
1995
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
344.4M
299.0M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
BNTC
CGC
Price
$9.20
$0.57
Analyst Decision
Strong Buy
Buy
Analyst Count
8
3
Target Price
★ $23.29
$1.77
AVG Volume (30 Days)
177.7K
★ 2.5M
Earning Date
11-24-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
6.67
★ 84.17
EPS
N/A
★ N/A
Revenue
N/A
★ $12,759,000.00
Revenue This Year
N/A
$18.45
Revenue Next Year
N/A
$7.42
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.89
$0.58
52 Week High
$14.39
$2.38

Technical Indicators

Market Signals
Indicator
BNTC
CGC
Relative Strength Index (RSI) 49.46 29.63
Support Level $8.14 N/A
Resistance Level $9.29 $0.76
Average True Range (ATR) 0.64 0.04
MACD 0.16 -0.00
Stochastic Oscillator 53.62 6.10

Price Performance

Historical Comparison
BNTC
CGC

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Share on Social Networks: